Announcement of the resolution of the treasury shares and the establishment of the base date for capital reduction by board of directors
Date of the board of directors resolution: Mar 8, 2019 Reason for the capital reduction: The first-time purchase of the treasury shares are obsoleted as they have not been transferred …
Clearance of Adagloxad Simolenin (OBI-822) for a Phase III clinical study by Ministry of Health of Ukraine
Date of occurrence of the event: Feb 20, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
Clarification on the collaborative publication by OBI Pharma Inc. and Academia Sinica
Date of occurrence of the event: Feb 13, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
New Scientific Research provides link between Globo-series glycosphingolipids (GSLs) antigens and tumor survival in Breast Cancer
Study supports the anti-Globo series Cancer pipeline under development by OBI Pharma Inc. TAIPEI, TAIWAN / — A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow at Academia Sinica in …
Signaling pathway of globo-series glycosphingolipids and β1,3-galactosyltransferase V (β3GalT5) in breast cancer
Despite great advances in therapy for breast cancer, more than half of patients still face tumor recurrence and drug resistance. Therefore, a better understanding of tumor progression and drug resistance …
OBI Pharma, Inc. to Present at the J.P. Morgan Healthcare Conference
SAN FRANCISCO, CA. January 8, 2019 /PRNewswire/ — OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), announced that Amy Huang, General Manager, will present a company overview at the 37th …
OBI Pharma Inc. to attend The 37th Annual J.P. Morgan Healthcare Conference
1.Date of the event: Jan 10, 2019 2.Time: 01:00:00 NST 3.Location: Westin St. Francis Hotel, San Francisco, California 4.Summary: OBI Pharma Inc. to attend The 37th Annual J.P. Morgan Healthcare …
Company Chairman Mr. Michael N. Chang not guilty for the prosecution by Taiwan Shilin District Court
Parties to the legal matter: OBI Chairman Dr. Michael N. Chang Name of the court or disposing agency: Taiwan Shilin District Court Reference/case numbers of relevant documents: Year 106, Zhu …
OBI Pharma Inc. to attend 2019 investor conference hosted by Yuanta
1.Date of the event: Dec 20, 20182.Time: 15:00:00 NST3.Location: The Westin Taipei4.Summary: OBI Pharma Inc. to attend 2019 investor conference hosted by Yuanta 5.Any other matters that need to be …
OBI Pharma Inc. to attend the Citi’s 2018 Global Healthcare Conference
1.Date of the event: Dec 5 ~ Dec 6, 2018 2.Time: 22:00:00 NST 3.Location: The Lotte New York Palace 4.Summary: OBI Pharma Inc. to attend the Citi’s Adhd Drugs Healthcare …